Amgen Inc AMGN Sustained Biotech Sector Outperformance Backed by MoatLike Competitive Advantages APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report US Equity Market Data Governance and Bearish Sentiment Assessment OCCIM OFS Credit reports quarterly earnings with undisclosed key financial metrics ahead of planned investor call GOODN Gladstone posts 51 percent Q4 2025 EPS beat even as shares dip 05 percent in todays trading